• SE Asia (HQ)

    +65 3158 9910

  • Australia

    1300 798 820

  • New Zealand

    +64 9801 0299

Specialised Therapeutics Asia to License a Promising Anti-Cancer Compound Lurbinectedin (PM1183) for South East Asia, Australia and New Zealand